Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.

Journal of Alzheimer's disease : JAD - 1 Jan 2015

Bhattacharya Soumee, Maelicke Alfred, Montag Dirk

Abstract excerpt

The plant alkaloid galantamine is an established symptomatic drug treatment for Alzheimer's disease (AD), providing cognitive and global relief in human patients. However, as an acetylcholinesterase inhibitor, gastrointestinal side effects limit the dosage and duration of treatment. Memogain (Gln...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Intranasal
Share to Cholinesterase Inhibitors
Share to Conditioning, Psychological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Muscle Strength

Share to Plaque, Amyloid

Share to Presenilin-1

Share to Prodrugs

Source

Identifiers

PMID: 25720404
DOI: 10.3233/JAD-142421

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25720404-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.PMID 25720404Read ↗

Oral Administration of Euonymus alatus Leaf Extract Ameliorates Alzheimer’s Disease Phenotypes in 5xFAD Transgenic MiceSemantic proximity Read ↗

Beyond Symptom Management: FAAH Inhibition as a Path to Mitigate Alzheimer’s Disease Progression in Mouse Models of AmyloidosisSemantic proximity Read ↗

Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.Semantic proximity Read ↗

Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer’s DiseaseSemantic proximity Read ↗

Fluvoxamine maleate ameliorates Alzheimer disease pathology by mitigating amyloid-beta load and neuroinflammation in 5XFAD miceSemantic proximity Read ↗

Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stageSemantic proximity Read ↗

Mildronate improves cognition and reduces amyloid‐β pathology in transgenic Alzheimer's disease miceSemantic proximity Read ↗

Effect of Acetylcholinesterase Inhibitors on the Cognitive Impairments in Transgenic Drosophila Model of Alzheimer’s DiseaseSemantic proximity Read ↗

Ethyl caffeate ameliorated amyloid‐beta42 protein‐associated toxicity in PC12 cells andDrosophila melanogasterSemantic proximity Read ↗

Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory.Semantic proximity Read ↗

Intranasal Administration of a Polyethylenimine-Conjugated Scavenger Peptide Reduces Amyloid-β Accumulation in a Mouse Model of Alzheimer's Disease.Semantic proximity Read ↗

Arginase Inhibition Supports Survival and Differentiation of Neuronal Precursors in Adult Alzheimer’s Disease MiceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.